Hinge Health (HNGE) CFO James Budge Sells Shares

What Happened

• James Budge, Chief Financial Officer of Hinge Health (HNGE), sold a total of 55,561 shares in multiple open-market transactions on September 10, 2026, generating approximately $4,969,999 in proceeds. The trades were executed in five tranches: 13,261 @ $88.22 ($1,169,924); 13,807 @ $89.00 ($1,228,862); 21,783 @ $90.05 ($1,961,516); 5,910 @ $90.76 ($536,403); and 800 @ $91.62 ($73,294). These disposals are reported as sales (S).

Key Details

• Transaction date: all sales on 2026-09-10; Form 4 filed 2026-09-11 (timely filing).
• Aggregate shares sold: 55,561; aggregate proceeds: ~$4.97 million.
• Per-line price ranges / footnotes: the filing includes weighted-average prices and price ranges for each line (see footnotes F2–F6). The seller offers to provide a full breakdown of shares sold at each price upon request.
  • F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Budge and his spouse on June 11, 2026.
  • F2–F6: Each line reports weighted-average sale prices and the lowest/highest prices within those lines (ranges provided in the filing).
• Shares owned after transaction: not specified in the provided filing details.
• Transaction code: S = Sale.

Context

• These sales were made under a pre-established Rule 10b5-1 plan, which typically indicates preplanned, systematic dispositions rather than immediate reactions to inside information. Sales do not necessarily signal a negative view of the company; purchases are generally viewed as a stronger bullish signal for investors.
• For retail investors: track insider purchases more closely as potential bullish signals. Sales by executives can be routine (diversification, tax planning, liquidity) — this filing documents the mechanics and timing but does not state motivation.